Trillium Asset Management, LLC Merck & Co., Inc. Transaction History

Trillium Asset Management, LLC

$4 Billion
Q3 2024

A detailed history of Trillium Asset Management, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Trillium Asset Management, LLC holds 392,321 shares of MRK stock, worth $38.5 Million. This represents 1.11% of its overall portfolio holdings.

Number of Shares

392,321

Previous 398,094 1.45%

Holding current value

$38.5 Million

Previous $49.3 Million 9.6%

% of portfolio

1.11%

Previous 1.26%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$111.15 - $128.97 $641,668 - $744,543	-5,773 Reduced 1.45%	392,321 $44.6 Million
Q2 2024 Aug 07, 2024	SELL	$123.8 - $132.96 $7.97 Million - $8.56 Million	-64,382 Reduced 13.92%	398,094 $49.3 Million
Q1 2024 May 09, 2024	SELL	$113.24 - $131.95 $348,213 - $405,746	-3,075 Reduced 0.66%	462,476 $61 Million
Q4 2023 Feb 08, 2024	SELL	$100.18 - $109.02 $1.24 Million - $1.35 Million	-12,346 Reduced 2.58%	465,551 $50.8 Million
Q3 2023 Nov 07, 2023	SELL	$102.95 - $114.33 $3.26 Million - $3.62 Million	-31,696 Reduced 6.22%	477,897 $49.2 Million
Q2 2023 Aug 09, 2023	SELL	$108.61 - $118.38 $43,987 - $47,943	-405 Reduced 0.08%	509,593 $58.8 Million
Q1 2023 May 08, 2023	BUY	$102.94 - $114.86 $4.39 Million - $4.89 Million	42,602 Added 9.11%	509,998 $54.3 Million
Q4 2022 Feb 07, 2023	SELL	$87.44 - $112.11 $911,037 - $1.17 Million	-10,419 Reduced 2.18%	467,396 $51.8 Million
Q3 2022 Nov 09, 2022	SELL	$84.53 - $94.96 $366,353 - $411,556	-4,334 Reduced 0.9%	477,815 $41.2 Million
Q2 2022 Aug 08, 2022	BUY	$83.49 - $94.64 $4.21 Million - $4.78 Million	50,456 Added 11.69%	482,149 $43.9 Million
Q1 2022 May 04, 2022	SELL	$73.51 - $82.4 $2.24 Million - $2.51 Million	-30,427 Reduced 6.58%	431,693 $35.4 Million
Q4 2021 Feb 08, 2022	BUY	$72.28 - $90.54 $533,643 - $668,456	7,383 Added 1.62%	462,120 $35.4 Million
Q3 2021 Nov 12, 2021	BUY	$71.68 - $78.83 $1.11 Million - $1.22 Million	15,425 Added 3.51%	454,737 $34.2 Million
Q2 2021 Aug 06, 2021	BUY	$70.31 - $77.77 $504,263 - $557,766	7,172 Added 1.66%	439,312 $34.1 Million
Q1 2021 May 10, 2021	SELL	$68.86 - $81.11 $4.74 Million - $5.58 Million	-68,832 Reduced 13.74%	432,140 $33.3 Million
Q4 2020 Feb 12, 2021	BUY	$71.77 - $79.65 $122,224 - $135,643	1,703 Added 0.34%	500,972 $41 Million
Q3 2020 Nov 09, 2020	SELL	$73.18 - $82.95 $2.53 Million - $2.86 Million	-34,516 Reduced 6.47%	499,269 $41.4 Million
Q2 2020 Aug 06, 2020	BUY	$70.42 - $80.13 $320,833 - $365,072	4,556 Added 0.86%	533,785 $41.3 Million
Q1 2020 May 07, 2020	BUY	$63.36 - $87.82 $3.05 Million - $4.23 Million	48,130 Added 10.0%	529,229 $40.7 Million
Q4 2019 Feb 10, 2020	BUY	$77.58 - $87.54 $757,879 - $855,178	9,769 Added 2.07%	481,099 $43.8 Million
Q3 2019 Nov 06, 2019	BUY	$76.08 - $82.93 $461,196 - $502,721	6,062 Added 1.3%	471,330 $39.7 Million
Q2 2019 Aug 08, 2019	SELL	$69.84 - $81.59 $160,212 - $187,167	-2,294 Reduced 0.49%	465,268 $39 Million
Q1 2019 May 06, 2019	SELL	$69.58 - $79.36 $48,706 - $55,552	-700 Reduced 0.15%	467,562 $38.9 Million
Q4 2018 Feb 08, 2019	SELL	$65.24 - $75.71 $158,794 - $184,278	-2,434 Reduced 0.52%	468,262 $35.8 Million
Q3 2018 Nov 09, 2018	BUY	$57.69 - $67.84 $105,976 - $124,622	1,837 Added 0.39%	470,696 $33.4 Million
Q2 2018 Aug 01, 2018	BUY	$50.83 - $59.72 $1.07 Million - $1.25 Million	20,958 Added 4.68%	468,859 $28.5 Million
Q1 2018 May 09, 2018	BUY	$50.96 - $59.23 $816,939 - $949,516	16,031 Added 3.71%	447,901 $24.4 Million
Q4 2017 Feb 01, 2018	SELL	$51.62 - $61.64 $835,314 - $997,458	-16,182 Reduced 3.61%	431,870 $24.3 Million
Q3 2017 Nov 02, 2017	BUY	$58.67 - $63.13 $26.3 Million - $28.3 Million	448,052	448,052 $28.7 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trillium Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trillium Asset Management, LLC with notifications on news.

Account

Trillium Asset Management, LLC Merck & Co., Inc. Transaction History